USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | - | - | $-1.03 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | - | - | $0.00 |
89bio's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 9 | $-4.74 | $-6.37 | $-2.51 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-4.54 | $-4.06 | $-4.10 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 8 | $1.25M | $0.00 | $10.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $-1.31 | - | - |
| Nov 11, 2021 | Sep 2021 | $-1.07 | $-1.41 | -31.28% |
| Aug 13, 2021 | Jun 2021 | $-0.81 | $-1.03 | -27.16% |
| May 12, 2021 | Mar 2021 | $-0.65 | $-0.74 | -13.85% |
| Mar 24, 2021 | Dec 2020 | $-0.94 | $-0.63 | 33.12% |
| Nov 10, 2020 | Sep 2020 | $-0.89 | $-0.86 | 3.15% |
| Aug 13, 2020 | Jun 2020 | $-0.81 | $-0.85 | -5.46% |
| May 13, 2020 | Mar 2020 | $-0.86 | $-0.76 | 11.11% |
| Mar 18, 2020 | Dec 2019 | $-1.08 | $-2.58 | -138.89% |
| Dec 18, 2019 | Sep 2019 | $-1.08 | $-1.36 | -25.93% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $-4.49 | $-3.18 | - |
| Mar 24, 2021 | Dec 2020 | $-3.13 | $-3.10 | - |
| Mar 18, 2020 | Dec 2019 | $-13.95 | $-3.94 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $0.00 | - | - |
| Nov 11, 2021 | Sep 2021 | $0.00 | $0.00 | - |
| Aug 13, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 12, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 24, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 10, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 13, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 13, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 18, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Dec 18, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 22, 2022 | Dec 2021 | $0.00 | - | - |
| Mar 24, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 18, 2020 | Dec 2019 | $0.00 | $0.00 | - |
ETNB's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.
89bio's previous earnings date was May 10, 2022 for its fiscal quarter ended Mar 31, 2022.
89bio's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.
ETNB's earnings per share (EPS) was $-3.10, beating the consensus analysts forecast of $-3.13 by -0.96% , and higher than the previous year's EPS (Dec 2019) by -21.32%.
Revenues were $0.00.
The company reported a net income of $-49.50M.
89bio reported a free cash flow of $-46.37M for its fiscal year, compared to $-25.60M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
